Whereas the mean tumor size in HER2-positive SDBC in PDP series was 1.4 cm, a statistically significant higher mean size (2.65 cm) was observed in the non-screen detected HER2-positive BC group (p < 0.012). This evidence concerns the gene ERBB2 and breast cancer.